Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | 02182135 |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Awarded to (2 suppliers)
| Award value: | £46,600,000 |
| Award decision date: | 11 March 2024 |
| Award status: | Active |
Project Title: NHS National Framework for Tocilizumab - March 2024 Offer reference number: CM/PHR/23/5702 CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
3 January 2024
Closed
Estimated Value
£46,600,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £46,600,000 |
| Release Date: | 8 April 2024 |
| Application Deadline: | 3 January 2024 |
| Contract Start Date: | 1 March 2024 |
| Contract End Date: | 28 February 2025 |
| Contract Duration: | 1.0 years |
| Procurement ID (OCID): | ocds-b5fd17-57b54e85-da9c-4332-bb93-8a7359735da5 |
| Notice Reference: | 740537ba-c484-46a9-82ca-abe7901d188e-738925 |
View Original Notice
Access the full notice on the official portal